Back to
Driehaus Capital Management LLC
APGE
13 quarters
Position history for
Driehaus Capital Management LLC's holdings in APOGEE THERAPEUTICS INC
As of its Q2 2026 13F, Driehaus Capital Management held 1,740,101 shares of APGE (Apogee Therapeutics), worth $231M. Driehaus Capital Management listed APGE in 12 quarterly 13F filings through Q2 2026. APGE was 1.3% of Driehaus Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$28.5M
Total Shares Change
-1.3M
Quarter-by-Quarter History